Tag: CBT > DEA Rescheduling: Page 8

South Carolina

Jamaica’s THC Exports to United States Leads CBT’s Most Popular Articles in February

Rescheduling, state legalization prospects, and Lume’s rapid rise in Michigan also ranked in Cannabis Business Times’ top 10 stories this month.

February 29, 2024

Regulations and Reform

DOJ Declines to Address Media Inquiry on Cannabis Rescheduling, Points to 2020 Resource Guide

A Department of Justice spokesperson said the government has nothing further to provide beyond its confirmation of review.

February 27, 2024

Cannabis Rescheduling

Former Police Chiefs, Prosecutors, Correctional Officials Urge Biden to Reschedule Cannabis

Officials who dedicated their careers to protecting public safety and reducing unnecessary arrests say cannabis prohibition has become problematic.

February 22, 2024

International

Jamaica Company Ships 1st Legal Exports of THC to United States For DEA Testing

Pure Jamaican elevates Jamaica as a global provider of legal cannabis with pharmaceutical THC product exports to the U.S. and Brazil.

February 22, 2024

International

Behind DEA’s 1975 Admission That Rescheduling Cannabis Does Not Violate International Treaty

The DEA’s refusal to reschedule cannabis nearly 50 years ago derived from HHS predecessor’s failure to recognize its medical value, not a 1961 treaty.

February 22, 2024

Legislation and Regulation

DEA, Attorney General Miss Deadline to Respond to 12 US Senators on Cannabis Rescheduling

The Drug Enforcement Administration continues to keep its process behind closed doors despite a congressional letter demanding transparency.

February 14, 2024

Federal Cannabis Legalization

VP Kamala Harris Touts Changing ‘Federal Marijuana Policy’ in Campaign Video

Many industry stakeholders and advocates pushed back, saying the White House hasn’t changed anything since Biden took office.

February 12, 2024

Cannabis Rescheduling

Congressman Presses DEA For Answers on Ongoing Cannabis Scheduling Review

U.S. Rep. Earl Blumenauer wrote to DEA Administrator Anne Milgram Feb. 8 for further details on the review process, including when the agency might publish its draft rule on the scheduling of cannabis.

February 8, 2024

Impacts of Cannabis Legalization

Cannabis Reform Momentum Unprecedented in Recent Years

In the past three years, the federal government has taken steps to provide more access to research, rescheduling may be on the horizon and nearly half of U.S. states have legalized adult-use cannabis.

February 8, 2024

Cannabis Rescheduling

GOP Candidate Nikki Haley Addresses Federal Cannabis Reform

During a recent CNN Republican Presidential Town Hall, CNN’s Jake Tapper asked GOP candidate Nikki Haley whether or not she would support the FDA's recent recommendation to reclassify cannabis to a Schedule III drug.

February 7, 2024

Cannabis Rescheduling

US Congressman Attempts to Sway DEA From Rescheduling Cannabis

Rep. Andy Harris claims the FDA’s eight-factor analysis on cannabis was “flawed,” leading to a “misguided” recommendation to reschedule.

February 2, 2024

Legislation and Regulation

12 US Senators Say Cannabis Should Be Descheduled, Demand Transparency From DEA

The dozen Democrats requested responses to six questions regarding the DEA’s rescheduling process.

January 30, 2024